News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Industry News Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) September 20, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Daily News Demasiados Elementos en Juego: La Existencia de Diferentes y Discordantes Directrices Hace que la Valoración del Riesgo de ECV sea Confusa Michael O'Riordan September 16, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016
News Daily News Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly Michael O'Riordan July 21, 2016
News Daily News La Infrautilización del Tratamiento Médico se asocia a Más Episodios Adversos en Pacientes Muy Ancianos Michael O'Riordan July 21, 2016
News Daily News The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say Shelley Wood July 19, 2016
News Daily News Debate Directrices EU vs. EE.UU: Según los Expertos las Diferencias son Importantes Shelley Wood July 19, 2016
News Daily News Un Nuevo Análisis Cuestiona el Mantra ‘Mejor Menos’, aunque los Expertos Piden Cautela Todd Neale June 22, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016